Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Hlavní autoři: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
American Society for Microbiology
2017
|
Podobné jednotky
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Autor: Chotsiri, P, a další
Vydáno: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Autor: Palang Chotsiri, a další
Vydáno: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
Autor: Bergstrand, M, a další
Vydáno: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
Autor: Myint, H, a další
Vydáno: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
Autor: Lwin, K, a další
Vydáno: (2012)